3-Hydroxy-3-methylglutaryl-CoA lyase

3-Hydroxy-3-methylglutaryl-CoA lyase is an enzyme. It is a ketogenic enzyme in the liver that catalyzes the formation of acetoacetate from HMG-CoA within the mitochondria. It also plays a prominent role in the catabolism of the amino acid leucine.

Structure

The HMGCL gene encodes a 34.5-kDa protein that is localized to the mitochondrion and peroxisome. Multible isoforms of the proteins are known due to alternative splicing. The major isoform is most highly expressed in the liver whereas isoform 2 is found in energy-demanding tissues including the brain, heart, and skeletal muscle.
Structure of the HMGCL protein has been resolved by X-ray crystallography at 2.1-Å resolution, and reveals that the protein may function as a dimer. Substrate access to the active site of the HMGCL enzyme involves substrate binding across a cavity located at the C-terminal end of a beta barrel structure. In addition, the lysine 48 residue which is mutated in patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency is also found to be necessary for substrate binding.
Electron density was observed indicating a bound metal ion, presumably Mg²⁺ due to its inclusion in the crystallization medium. The enzyme activity is dependent on the presence of the metal this was determined by mutating His233 to Ala233 and Asp42 to Asn42 and experiencing catalytic deficiency of 6.4E⁻³ k_cat/k_M and 1.3E⁻⁵ k_cat/k_M respectively. The substrate binding site includes arginine 41 making a salt bridge to the carboxylate of the hydroxyglutaric acid closest to metal ion. A mutation in Arg 41 results in a drastic decrease of catalytic activity. The extreme decrease in efficiency suggests the direct involvement in the chemistry of the catalytic reaction. This Arg41 also salt bridges to Glu72 to fold into the correct position and charge balance Arg41 to bind to the substrate.

Function

The HMGCL protein plays an essential role in breaking down dietary proteins and fats for energy. It catalyzes the reaction:
and requires a divalent metal ion as co-factor.
The enzyme is required for ketogenesis in the liver, and is also responsible for processing the amino acid leucine inside the mitochondrion
Deficiency
HMG-CoA lyase deficiency causes hypoketotic hypoglycemia similar to that is caused by HMGCS2 mutations but also leads to organic acid accumulation and metabolic acidosis due to altered leucine metabolism. This disorder can be mistaken for Reye syndrome because of the symptoms of vomiting, lethargy, and convulsions.

Clinical significance

Mutations in the HMGCL gene cause 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, a rare autosomal recessive inborn error of metabolism characterized by disruption of ketogenesis and L-leucine catabolism. To-date more than 30 different mutations including missense mutations of different residues have been associated with patients with HMGCLD in diverse families and ethnicities. HMGCLD typically presents in the first year of the patient's life after a fasting period. Clinical acute symptoms include vomiting, seizures, metabolic acidosis, hypoketotic hypoglycemia, and lethargy.

Interactions

HMGCL interacts with itself to form homodimers and homotetramers. It is also shown in yeast two-hybrid experiments to interact with DNAJA1.